Skip to main content
. Author manuscript; available in PMC: 2011 Nov 15.
Published in final edited form as: Clin Cancer Res. 2010 Oct 5;16(22):5402–5413. doi: 10.1158/1078-0432.CCR-10-1491

Table 4.

Clinicopathologic and molecular features of MUTYH mutation carriers

Case Age Sex Tumor
location
Stage Differentiation Mucinous
production
MSI
status
MMR IHC Other
tumors
Synchronous
adenomas (no.)
Family history* KRAS
status
MUTYH
mutation
52 46 M Rectum III Moderately No MSS Normal Colon (46) Yes (5) Colon (brother, 43) wt Y176C/1138delC
Larynx (father, 33)
Breast (mother, 50)
Thyroid (mother, 70)
Breast (maternal aunt, 60)
95D 43 F Rectum III Well No MSS Normal No No Breast (mother, 67) ND G393D/G393D
137D 47 F Sigmoid II Well No MSS Normal No Yes (1) ND ND G393D/G393D
31D 45 M Ascending II Well No MSS ND No Yes (2) Colonic polyposis (brother, ?) G12C G393D/T474fs488X
Colonic polyposis (sister, ?)
Colon (uncle, 80)
Colon (cousin, 48)
38D 48 F Rectum I ND No MSS Normal No No No G12C Y176C/−
154D 40 M Ascending IV Well No MSI Loss of MSH6 No No Leukemia (father, 62) ND G393D/−
Prostate (grandfather, 70)
31 50 M Rectum IV Poorly Yes MSS Normal No No No wt G393D/−
2 33 F Rectum III Moderately No MSS Normal No No Endometrium (sister, 42) wt G393D/−
Endometrium (grandmother, 42)

Abbreviation: IHC, immunohistochemistry.

*

Affected relative and age at diagnosis are indicated between parentheses.